Ian D. Fier
Corporate Officer/Principal bei MOMENTA PHARMACEUTICALS, INC.
Aktive Positionen von Ian D. Fier
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2002 | - |
Karriereverlauf von Ian D. Fier
Ehemalige bekannte Positionen von Ian D. Fier
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BioTransplant, Inc.
 BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Ian D. Fier
| Tufts University | Undergraduate Degree |
| Boston University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Israel | 2 |
Operativ
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
BioTransplant, Inc.
BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Health Technology |
- Börse
- Insiders
- Ian D. Fier
- Erfahrung
